 |
|
|
| |
Continued Treatment of Early Nonresponders or Partial Virologic Responders With Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta Through Week 96 Leads to Improvement in Virologic and Biochemical Responses
|
| |
| |
EASL 2023 June 23 Vienna
Pietro Lampertico1,2, Heiner Wedemeyer3, Maurizia Rossana Brunetto4, Pavel Bogomolov5, Tatyana Stepanova6, Sandra Ciesek7, Annemarie Berger7, Dmitry Manuilov8, Qi An8, Audrey H Lau8, Ben L Da8, John F Flaherty8,
Renee-Claude Mercier8, Stefan Zeuzem9, Markus Cornberg3, Maria Buti10, Soo Aleman11
|
| |
|
|
|
|
|
